Next Article in Journal
Hsp90 Inhibitors and the Reduction of Anti-Cancer Drug Resistance by Non-Genetic and Genetic Mechanisms
Next Article in Special Issue
Why and How the Old Neuroleptic Thioridazine Cures the XDR-TB Patient
Previous Article in Journal
A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)
Previous Article in Special Issue
Chemotherapeutic Interventions Against Tuberculosis
Pharmaceuticals 2012, 5(8), 882-889; doi:10.3390/ph5080882

Notes on Article Versions

NoteDate
article html file updated24 January 2013 00:25 CET
article html file updated27 January 2013 03:13 CET
article html file updated29 January 2013 06:04 CET
article html file updated6 February 2013 09:49 CET
article html file updated7 February 2013 05:32 CET
article html file updated7 February 2013 14:29 CET
article xml file uploaded6 August 2013 16:06 CEST
article html file updated6 August 2013 16:07 CEST
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert